QQ客服 官方微博 反馈留言

	Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study (vol 10, 153, 2017)
	Liu, Xinyang; Qin, Shukui; Wang, Zhichao; Xu, Jianming; Xiong, Jianping; Bai, Yuxian; Wang, Zhehai; Yang, Yan; Sun, Guoping; Wang, Liwei
刊名	JOURNAL OF HEMATOLOGY & ONCOLOGY
	2018
卷号	11
ISSN号	1756-8722
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3609557
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Liu, Xinyang,Qin, Shukui,Wang, Zhichao,et al. Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study (vol 10, 153, 2017)[J]. JOURNAL OF HEMATOLOGY & ONCOLOGY,2018,11.
APA	Liu, Xinyang.,Qin, Shukui.,Wang, Zhichao.,Xu, Jianming.,Xiong, Jianping.,...&Li, Jin.(2018).Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study (vol 10, 153, 2017).JOURNAL OF HEMATOLOGY & ONCOLOGY,11.
MLA	Liu, Xinyang,et al."Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study (vol 10, 153, 2017)".JOURNAL OF HEMATOLOGY & ONCOLOGY 11(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。